We intend to bring high quality and affordable medicines to the patients, and we believe collaboration is the most efficient way to achieve this goal. We welcome collaboration in R&D.

We also actively seek to acquire products, technologies or companies with strategic value in the global market. In addition, we welcome inquiries from business development executives who would like to derive further value from their established brands through licensing partnerships.

Please address all business development inquiries to Kerri Yan, CEO.